IL1B and COVID-19: A meta-analysis of 77 prospective or retrospective cohort studies in adult patients with COVID-19 showed that IL-1β, IL-2R, IL-4, IL-6, IL-8, IL-10, and IL-17, inflammatory markers, were potential risk factors for severe SARS-CoV-2 infection or mortality.